Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers-Reference-Cited by-同舟云学术

Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers

Published:2003-05-09 Issue:5621 Volume:300 Page:949-949
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Bardelli Alberto¹,Parsons D. Williams¹,Silliman Natalie¹,Ptak Janine¹,Szabo Steve¹,Saha Saurabh¹,Markowitz Sanford¹,Willson James K. V.¹,Parmigiani Giovanni¹,Kinzler Kenneth W.¹,Vogelstein Bert¹,Velculescu Victor E.¹

Affiliation:

1. The Howard Hughes Medical Institute and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA. 3Howard Hughes Medical Institute and Ireland Cancer Center, University Hospitals of Cleveland and Case Western University, Cleveland, OH 44106, USA.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference6 articles.

1. Oncogenic kinase signalling

2. The Protein Kinase Complement of the Human Genome

3. Materials and methods are available as supporting material on Science Online.

4. B. J. Druker, Cancer Cell1, 31. (2002).

5. Single-letter abbreviations for the amino acid residues are as follows: A Ala; C Cys; D Asp; E Glu; F Phe; G Gly; H His; I Ile; K Lys; L Leu; M Met; N Asn; P Pro; Q Gln; R Arg; S Ser; T Thr; V Val; W Trp; and Y Tyr.

Cited by 430 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

2. EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses;Journal for ImmunoTherapy of Cancer;2024-08

3. A review on macrocyclic kinase inhibitors in clinical trials;International Journal of Pharmaceutical Chemistry and Analysis;2024-07-15

4. Potential role of the Eph/ephrin system in colorectal cancer: emerging druggable molecular targets;Frontiers in Oncology;2024-04-02

5. Glycaemic abnormalities induced by small molecule tryosine kinase inhibitors: a review;Frontiers in Pharmacology;2024-02-01